Literature DB >> 15624123

Phlorizin: a review.

Joel R L Ehrenkranz1, Norman G Lewis, C Ronald Kahn, Jesse Roth.   

Abstract

The dihydrochalcone phlorizin is a natural product and dietary constituent found in a number of fruit trees. It has been used as a pharmaceutical and tool for physiology research for over 150 years. Phlorizin's principal pharmacological action is to produce renal glycosuria and block intestinal glucose absorption through inhibition of the sodium-glucose symporters located in the proximal renal tubule and mucosa of the small intestine. This review covers the role phlorizin has played in the history of diabetes mellitus and its use as an agent to understand fundamental concepts in renal physiology as well as summarizes the physiology of cellular glucose transport and the pathophysiology of renal glycosuria. It reviews the biology and pathobiology of glucose transporters and discusses the medical botany of phlorizin and the potential effects of plant flavonoids, such as phlorizin, on human metabolism. Lastly, it describes the clinical pharmacology and toxicology of phlorizin, including investigational uses of phlorizin and phlorizin analogs in the treatment of diabetes, obesity, and stress hyperglycemia. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15624123     DOI: 10.1002/dmrr.532

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  186 in total

Review 1.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

2.  Phloridzin reduces blood glucose levels and improves lipids metabolism in streptozotocin-induced diabetic rats.

Authors:  Mahmood Najafian; Mohammad Zareain Jahromi; Mohammad Javad Nowroznejhad; Parastoo Khajeaian; Mohammad Mehdi Kargar; Mehdi Sadeghi; Amir Arasteh
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

Review 3.  Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

Authors:  Volker Vallon; Kumar Sharma
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-09       Impact factor: 2.894

4.  A fluorescence method for measurement of glucose transport in kidney cells.

Authors:  Amy B Blodgett; Rajendra K Kothinti; Ivan Kamyshko; David H Petering; Suresh Kumar; Niloofar M Tabatabai
Journal:  Diabetes Technol Ther       Date:  2011-04-21       Impact factor: 6.118

Review 5.  Efficacy and safety of SGLT2 inhibitors in the treatment of type 2 diabetes mellitus.

Authors:  Muhammad A Abdul-Ghani; Luke Norton; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 6.  SGLT2 inhibition--a novel strategy for diabetes treatment.

Authors:  Edward C Chao; Robert R Henry
Journal:  Nat Rev Drug Discov       Date:  2010-05-28       Impact factor: 84.694

7.  Functional role of sodium glucose transporter in high glucose-mediated angiotensin type 1 receptor downregulation in human proximal tubule cells.

Authors:  Rekha Yesudas; Russell Snyder; Thomas Abbruscato; Thomas Thekkumkara
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-30

Review 8.  Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.

Authors:  Tanya Wilcox; Christophe De Block; Arthur Z Schwartzbard; Jonathan D Newman
Journal:  J Am Coll Cardiol       Date:  2020-04-28       Impact factor: 24.094

9.  Mechanism of Increased LDL (Low-Density Lipoprotein) and Decreased Triglycerides With SGLT2 (Sodium-Glucose Cotransporter 2) Inhibition.

Authors:  Debapriya Basu; Lesley-Ann Huggins; Diego Scerbo; Joseph Obunike; Adam E Mullick; Paul L Rothenberg; Nicholas A Di Prospero; Robert H Eckel; Ira J Goldberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-09       Impact factor: 8.311

Review 10.  Canagliflozin-current status in the treatment of type 2 diabetes mellitus with focus on clinical trial data.

Authors:  Jagriti Bhatia; Nanda Gamad; Saurabh Bharti; Dharamvir Singh Arya
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.